Marty Whitman
Third Avenue Management
Third Avenue Management Park Ha Biological Technology Co, Ltd stake
total: 405
Third Avenue Management PHH trades
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Held since:
- 2014 Q1
- Held for:
- 2 quarters
- Latest activity:
- 2014 Q3
According to 2026 Q2 report, Third Avenue Management doesn't hold any Park Ha Biological Technology Co, Ltd (PHH) shares. To date, the estimated cost basis is nearly $25.78 for "buy" trades and estimated average "sell" price is $22.98. Third Avenue Management first purchased PHH in 2014 Q1, initially acquiring 954,725 shares. Since the initial investment in Park Ha Biological Technology Co, Ltd (PHH), Third Avenue Management has made 2 more transactions.
When did Third Avenue Management sell Park Ha Biological Technology Co, Ltd (PHH)?
Third Avenue Management sold off the entire Park Ha Biological Technology Co, Ltd (PHH) position in 2014 Q3.
When did Third Avenue Management buy Park Ha Biological Technology Co, Ltd (PHH)?
Third Avenue Management first invested in Park Ha Biological Technology Co, Ltd (PHH) in 2014 Q1 at the reported quarter-end price of $25.84 per share.
What's the cost basis of Third Avenue Management's PHH stake?
The estimated cost basis for Park Ha Biological Technology Co, Ltd (PHH) stake is around $25.78 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $25.78
- Weighted AVG sell price:
- $22.98
Third Avenue Management's historical trades in Park Ha Biological Technology Co, Ltd
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.